COVID-19の文脈でRAASに対する下垂体-標的腺軸の効果
Baofeng Wu1,2, Ru Li1,2, Qinhao Liu1,2
1Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China.
International journal of medical sciences
|August 27, 2025
まとめ
このレビューでは,下垂体ホルモンと軸がレニン-アニオテンシン-アルドステロン系 (RAAS) にどのように影響し,特に進行中のSARS-CoV-2再感染に関して,血圧と水分バランスに関する洞察を提供します.
科学分野:
- 内分泌学
- 心血管の生理学
- 腎臓生理学
背景:
- 甲状腺は,ホルモンの分泌を通して代謝,成長,生殖を調節するために不可欠です.
- レニン・アニオテンシン・アルドステロン系 (RAAS) は,血圧と水分バランスのために重要です.
- RAASの病理生理学的理解は,重要な臨床的進歩をもたらしました.
研究 の 目的:
- pituitary-target gland axes が RAAS に与える影響を検討する.
- 垂体ホルモンの水電位バランスと血圧への影響を調べる
- 持続的なSARS-CoV-2再感染の文脈で新しい視点を提供するためです.
主な方法:
- 下垂体ホルモンとRAASの相互作用に焦点を当てた文献レビュー.
- pituitary-thyroid, pituitary-adrenal, pituitary-growth hormone, pituitary-gonadal axesを調査した研究の分析
- 下垂体因子によるRAAS調節に関する現在の知識の統合.
主要な成果:
- pituitary-target gland axes は RAAS 活動を大きく調節する.
- 下垂体ホルモンは,水-電解質ホメオスタシスと血圧制御に複雑な役割を果たします.
- 相互作用は,ウイルス感染中の生理学的反応を理解する上で特に重要である.
結論:
- 垂体腺とその軸はRAASの重要な調節体です.
- これらの相互作用に関するさらなる研究は,血圧と液体バランスの管理のための戦略を向上させることができます.
- このレビューは,ホルモンおよび心血管の調節不全を含む状態の潜在的な治療目標を強調しています.
関連する概念動画
01:37Hypothalamic-Pituitary Axis
61.6K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
61.6K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
819
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
819
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
875
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
875
01:29Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
01:18Neural Regulation of Blood Pressure
3.4K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505